Patents by Inventor Timothy A. Quill

Timothy A. Quill has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sperm-Specific Cation Channel, Catsper2, and Uses Therefor
    Publication number: 20170164591
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper2) are disclosed. The CatSper2 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper2 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper2 activity, methods of genotyping subjects with respect to CatSper2, methods of diagnosing and treating CatSper2-mediated disorders, including infertility, as well as methods of doing business related to CatSper2-mediated disorders.
    Type: Application
    Filed: February 28, 2017
    Publication date: June 15, 2017
    Inventors: Dejian REN, David CLAPHAM, David L. GARBERS, Timothy A. QUILL
  • Sperm-specific cation channel, Catsper2, and uses therefor
    Patent number: 9618521
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper2) are disclosed. The CatSper2 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper2 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper2 activity, methods of genotyping subjects with respect to CatSper2, methods of diagnosing and treating CatSper2-mediated disorders, including infertility, as well as methods of doing business related to CatSper2-mediated disorders.
    Type: Grant
    Filed: April 10, 2014
    Date of Patent: April 11, 2017
    Assignees: Children's Medical Center Corporation, Board of Regents, The University of Texas System
    Inventors: Dejian Ren, David Clapham, David L. Garbers, Timothy A. Quill
  • Sperm-Specific Cation Channel, Catsper2, and Uses Therefor
    Publication number: 20140363813
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper2) are disclosed. The CatSper2 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper2 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper2 activity, methods of genotyping subjects with respect to CatSper2, methods of diagnosing and treating CatSper2-mediated disorders, including infertility, as well as methods of doing business related to CatSper2-mediated disorders.
    Type: Application
    Filed: April 10, 2014
    Publication date: December 11, 2014
    Inventors: Dejian REN, David CLAPHAM, David L. GARBERS, Timothy A. QUILL
  • Sperm-specific cation channel, CATSPER2, and uses therefor
    Patent number: 8729248
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper2) are disclosed. The CatSper2 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper2 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper2 activity, methods of genotyping subjects with respect to CatSper2, methods of diagnosing and treating CatSper2-mediated disorders, including infertility, as well as methods of doing business related to CatSper2-mediated disorders.
    Type: Grant
    Filed: January 29, 2008
    Date of Patent: May 20, 2014
    Assignees: Children's Medical Center Corporation, Board of Regents, The University of Texas System
    Inventors: Dejian Ren, David Clapham, David L. Garbers, Timothy A. Quill
  • SPERM-SPECIFIC CATION CHANNEL, CATSPER2, AND USES THEREFOR
    Publication number: 20090104604
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper2) are disclosed. The CatSper2 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper2 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper2 activity, methods of genotyping subjects with respect to CatSper2, methods of diagnosing and treating CatSper2-mediated disorders, including infertility, as well as methods of doing business related to CatSper2-mediated disorders.
    Type: Application
    Filed: January 29, 2008
    Publication date: April 23, 2009
    Applicants: CHILDREN'S MEDICAL CENTER CORPORATION, BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Dejian REN, David CLAPHAM, David L. GARBERS, Timothy A. QUILL
  • Sperm-specific cation channel, CatSper2, and uses therefor
    Patent number: 7339029
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper2) are disclosed. The CatSper2 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper2 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper2 activity, methods of genotyping subjects with respect to CatSper2, methods of diagnosing and treating CatSper2-mediated disorders, including infertility, as well as methods of doing business related to CatSper2-mediated disorders.
    Type: Grant
    Filed: April 21, 2004
    Date of Patent: March 4, 2008
    Assignee: Children's Medical Center Corporation
    Inventors: Deijan Ren, David E. Clapham, David L. Garbers, Timothy A. Quill
  • Sperm-specific cation channel, catSper2, and uses therefor
    Publication number: 20050142566
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper2) are disclosed. The CatSper2 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper2 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper2 activity, methods of genotyping subjects with respect to CatSper2, methods of diagnosing and treating CatSper2-mediated disorders, including infertility, as well as methods of doing business related to CatSper2-mediated disorders.
    Type: Application
    Filed: April 21, 2004
    Publication date: June 30, 2005
    Applicants: Children's Medical Center Corporation, Board of Regents, The University of Texas System
    Inventors: Dejian Ren, David Clapham, David Garbers, Timothy Quill